SNFGE SNFGE
 
Thématique :
- Foie
Originalité :
Réexamen
Solidité :
Intermédiaire
Doit faire évoluer notre pratique :
Immédiatement
 
 
Nom du veilleur :
Professeur Dominique VALLA
Coup de coeur :
 
 
The Lancet
  2016/09  
 
  2016 Sep 10;388(10049):1115-26  
  doi: 10.1016/S0140-6736(16)30769-3  
 
  Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.  
 
  Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL  
  https://www.ncbi.nlm.nih.gov/pubmed/?term=Kamarulzaman+A1%2C+Reid+SE2%2C+Schwitters+A3%2C+Wiessing+L4%2C+El-Bassel+N5%2C+Dolan+K6%2C+Moazen+B7%2C+Wirtz+AL8%2C+Verster+A3%2C+Altice+FL9.  
 
 

Abstract

The prevalence of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis are higher in prisons than in the general population in most countries worldwide. Prisons have emerged as a risk environment for these infections to be further concentrated, amplified, and then transmitted to the community after prisoners are released. In the absence of alternatives to incarceration, prisons and detention facilities could be leveraged to promote primary and secondary prevention strategies for these infections to improve prisoners health and reduce risk throughout incarceration and on release. Effective treatment of opioid use disorders with opioid agonist therapies (eg, methadone and buprenorphine) prevents blood-borne infections via reductions in injection in prison and after release. However, large gaps exist in the implementation of these strategies across all regions. Collaboration between the criminal justice and public health systems will be required for successful implementation of these strategies.

 
Question posée
 
Revue sur la prise en charge des infections transmises par le sang dans les prisons.
 
Question posée
 
-
 
Commentaires

Très utile et pas seulement pour ceux qui travaillent en prison.

 
www.snfge.org